drugset / Trial / NCT00911339

Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents

NCT00911339 ↗

Phase 3 Terminated 13 enrolled Fondazione IRCCS Policlinico San Matteo di Pavia
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the extent of the mobilization of endothelial progenitor cells induced by low versus high dose atorvastatin after 4 weeks of treatment, in patients treated with anti-CD 34 antibodies coated stent.

Timeline

Start
2009-01
Primary completion
2021-05-13
Completion
2021-05-13

Outcome

Outcome not reported

Stopped: “prematurely interrupted because of difficulty in enrolment of patients.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 10 mg —
Comparator Atorvastatin Small molecule 80 mg —